V001-BCMA
/ Tongji Hospital, Cancer Hospital of Chinese Academy of Medical Sciences
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 10, 2026
A Platform Study of In Vivo CAR-T for Treating Advanced Malignant Tumors Based on Target Screening
(clinicaltrials.gov)
- P1 | N=50 | Recruiting | Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
New P1 trial • Hematological Malignancies • Lung Cancer • Multiple Myeloma • Small Cell Lung Cancer • Solid Tumor • DLL3
1 to 1
Of
1
Go to page
1